Boston Scientific, Johnson & Johnson, GE HealthCare, and Tempus AI are leveraging AI in various medical applications to improve diagnostics and treatments. AI is playing a crucial role in transforming clinical workflows and patient care by analyzing patient-specific data to guide treatment plans. Boston Scientific is investing in AI to enhance procedural outcomes, while Johnson & Johnson is focusing on robotic surgery and digital analytics. GE HealthCare is advancing AI-powered imaging, and Tempus AI is providing precision medicine solutions. Each company has a Zacks Rank #2 (Buy) and promising growth prospects.

Boston Scientific is utilizing AI in heart diagnostics, arrhythmia mapping, and coronary imaging to enhance procedural outcomes. Johnson & Johnson is integrating AI in robotic surgery and digital analytics for improved patient care. GE HealthCare Technologies is leveraging AI in imaging and diagnostics, while Tempus AI is advancing precision medicine solutions through the practical application of artificial intelligence in healthcare. All four companies have a Zacks Rank #2 (Buy) and are poised for growth in the AI-driven medical device industry.

Read more at Zacks Investment Research: 4 Medical Devices Behemoths to Buy Amid Extensive AI Applications – August 22, 2025